Macrogenics (MGNX) Misses Q1 EPS by 110c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.61), $1.10 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $24.5 million versus the consensus estimate of $106.5 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Hyperscale Data launches $300M at-the-market stock offering
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals